Pediatric genitourinary tumors.
During the past two decades, highly effective multimodality therapy involving surgery, chemotherapy, and radiation has been developed through consecutive national and international study protocols for childhood genitourinary cancers with the model being Wilms' tumor. These studies represent a landmark achievement in the history of pediatric oncology and mark the success of multi-institutional studies. With the excellent survival rates that have been established, current interest is now directed toward examining survivors for long-term treatment complications and minimizing the side effects while preserving treatment efficacy. In addition, new developments in the molecular biology of Wilms' tumor have made this neoplasm a model for understanding the molecular and genetic aspects of tumorigenesis. This article reviews some of the publications from 1992 on pediatric genitourinary tumors.
Fichtner
J
J
Stanford University, California.
Dairiki Shortliffe
L M
LM
D002648:Child; D005260:Female; D005833:Genital Neoplasms, Female / Q000235:genetics / Q000473:pathology / Q000628:therapy; D005834:Genital Neoplasms, Male / Q000235:genetics / Q000473:pathology / Q000628:therapy; D006801:Humans; D008297:Male; D012208:Rhabdomyosarcoma / Q000235:genetics / Q000473:pathology / Q000628:therapy; D013736:Testicular Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy; D014571:Urologic Neoplasms / Q000235:genetics / Q000473:pathology / Q000628:therapy; D009396:Wilms Tumor / Q000235:genetics / Q000473:pathology / Q000628:therapy